Responses to influenza vaccination in different T-cell subsets: A comparison of healthy young and older adults

Vaccine

Volumn 16, Issue 18, 1998, Pages 1742-1747

  McElhaney, Janet E ^a   Upshaw, Craig M ^a   Hooton, Jonathan W ^a   Lechelt, Katherine E ^a   Meneilly, Graydon S ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Age related changes; Aged; Cytokines; Cytotoxic T lymphocytes; Granzyme B; Helper T lymphocytes; Influenza vaccination

Indexed keywords

GRANZYME B; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; AGE; AGED; ARTICLE; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; NORMAL HUMAN; PRIORITY JOURNAL; PROPHYLAXIS;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIBODIES, VIRAL; CELLS, CULTURED; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 0032212399     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00133-9     Document Type: Article

References (26)

1. 1 Ahmed, A., Nicholson, K. and Nguyen-Van-Tam, J. Reduction in mortality associated with influenza during 1989-90 epidemic. Lancet 1995, 346, 591-595.
2. 2 Govaert, M., Thijs, C., Masurel, N., Sprenger, M., Dinant, G. and Knottnerus, J. The efficacy of influenza vaccination in elderly individuals - a randomized double-blind placebo-controlled trial. J. Am. Med. Assoc. 1994, 272, 1661-1665.
3. 3 Gross, P., Hermogenes, A., Sacks, H., Lau, J. and Levandowski, R. The efficacy of influenza vaccine in elderly persons - a meta-analysis and review of the literature. Ann. Intern. Med. 1995, 123, 518-527.
4. 4 Nichol, K., Margolis, K., Wuorenma, J. and Von Sternberg, T. The efficacy and cost-effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. 1994, 331, 778-784.
5. 5 Yap, K.L., Ada, G.L. and McKenzie, F.C. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with live influenza virus. Nature 1978, 273, 238-239.
6. 6 Yap, K.L. and Ada, G.L. Cytotoxic T-cells in the lungs of mice infected with influenza A virus. Scand. J. Immunol. 1978, 7, 73-80.
7. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med. 1994, 180, 1273-1282.
8. 8 Hobson, D., Curry, R., Beare, A. and Gardner, A. The role of serum hemagglutination-inhibiting antibody in protection against challenger infection with influenza A2 and B virus. J. Hyg. 1972, 70, 767-777.
9. 9 D'Alessio, D. and Cox, P. JrJr et al. Failure of inactivated influenza vaccine to protect an aged population. J. Am. Med. Assoc. 1969, 210, 485-489.
10. 10 Ferry, B., Evered, M. and Morrison, E. Different protection rates in various groups of volunteers given subunit influenza vaccine in 1976. J. Infect. Dis. 1979, 39, 237-241.
11. 11 Govaert, T., Sprenger, M., Dinant, G., Aretz, K., Masurel, N. and Knottnerus, J. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 1994, 12, 1185-1189.
12. + T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitro. J. Virol. 1991, 65, 6071-6076.
13. h2: reliable paradigm or dangerous dogma? Vaccine 1997, 18, 387-392.
14. h2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989, 7, 145-173.
15. 15 Ramsay, A.J., Ruby, J. and Ramshaw, I.A. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 1993, 14, 155-157.
16. 16 Scherle, P.A. and Gerhard, W. Differential ability of B-cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo. Proc. Natl. Acad. Sci. USA 1988, 85, 4446-4450.
17. 17 Biddison, W.E., Sharrow, S.O. and Shearer, G.M. T-cell subpopulations required for the human cytotoxic T lymphocyte response to influenza virus: evidence for T-cell help. J. Immunol. 1981, 127, 487-491.
18. 18 McElhaney, J.E., Pinkoski, M.J., Au, D., Lechelt, K.E., Bleackley, R.C. and Meneilly, G.S. Helper and cytotoxic T lymphocyte responses to influenza vaccination in healthy compared to diabetic elderly. Vaccine 1996, 14, 539-544.
19. 19 McElhaney, J.E., Meneilly, G.S., Lechelt, K.E. and Bleackley, R.C. Split-virus influenza vaccines: do they provide adequate immunity in the elderly? J. Gerontol. 1994, 49, M37-M43.
20. 20 McElhaney, J.E., Gravenstein, S., Upshaw, C.M., Hooton, J.W., Krause, P., Drinka, P., 1997. Immune response to influenza vaccination in institutionalized elderly: effect on different T-cell subsets. Vaccine 1998, 16, 403-409.
21. 21 Hooton, J., Gibbs, C. and Paetkau, V. Interaction of interleukin-2 with cells: quantitative analysis of effects. J. Immunol. 1985, 135, 2464-2473.
22. 22 McElhaney, J.E., Pinkoski, M.J., Upshaw, C. and Bleackley, R.C. The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity. J. Immunol. Meth. 1996, 190, 11-26.
23. 23 Gorse, G. and Belshe, R.B. Enhancement of anti-influenza A virus cytotoxicity following influenza. A virus vaccination in older, chronically ill adults. J. Clin. Microbiol. 1990, 28, 2539-2550.
24. 24 Powers, D.C. and Belshe, R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J. Inf. Dis. 1993, 167, 584-592.
25. 25 Gorse, G.J., Campbell, M.J., Otto, E.E., Powers, D.C., Chambers, G.W. and Newman, F.K. Increased anti-influenza A virus cytotoxic T-cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine. J. Infec. Dis. 1995, 172, 1-10.
26. 26 Donnelly, J., Friedman, A., Ulmer, J. and Liu, M. Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination. Vaccine 1997, 15, 865-868.